Extends federal support and authorization for vector-borne disease surveillance, research, and coordination through 2030 to preserve public-health capacity, while increasing federal spending and shifting decision-making toward HHS with some loss of transparency and external collaboration.
State and local health departments and public-health programs will keep federal funding and authorization through 2030, maintaining surveillance and response capacity and avoiding disruption to ongoing grants, personnel, and projects.
Researchers, regional centers of excellence, and health systems will retain authorized support for research, training, and national strategy activities on tick- and vector-borne diseases through 2030, sustaining expertise and coordination.
State and local governments and nonprofit partners may lose formal collaborative roles because changing 'in coordination with' to 'acting through' centralizes decision-making within HHS.
The public and stakeholders may have reduced transparency about who advises the program because a named advisory group citation is replaced with the broader phrase 'appropriate individuals.'
Taxpayers could face higher federal spending over the long term because extending the program authorization increases budgetary commitments without specified offsets.
Based on analysis of 2 sections of legislative text.
Extends federal authorization dates for national vector‑borne disease strategy, regional centers, and health‑department support to 2026–2030 and streamlines coordination wording.
Official title: Reauthorize the Kay Hagan Tick Act, and for other purposes.
Introduced July 23, 2025 by Susan Margaret Collins · Last progress September 15, 2026
Extends and updates federal program authorities for tick‑borne and other vector‑borne disease activities by amending two provisions of the Public Health Service Act. It shortens some coordination wording and prolongs existing authorized program years from 2026 through 2030 for the national strategy, regional centers of excellence, and enhanced support to health departments. The bill does not create new programs or add specific funding amounts; it mainly updates statutory text and extends the date ranges that authorize ongoing program activities for another five-year period.